Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chemotherapy-induced Peripheral Neuropathy
100%
Healthcare Professionals
100%
Patient Assessment
100%
Prospective Evaluation
100%
Total Neuropathy Score
100%
Cancer Treatment
41%
Neurotoxicity
41%
Functional Assessment
41%
Gynecologic Oncology Group
41%
Minimal Clinically Important Difference
23%
Neuropathy
17%
Chemotherapy
11%
Patient-completed
11%
Nurse Assessment
11%
Neurotoxic Chemotherapy
11%
Clinically Significant
5%
Clinical Trials
5%
United States
5%
European Union
5%
Australia
5%
Patient-centered
5%
Consecutive Patients
5%
Chemotherapy Regimen
5%
Clinical Assessment
5%
Neurological Examination
5%
Correlation Index
5%
Change from Baseline
5%
Change Score
5%
Spearman Correlation
5%
Methods for Detection
5%
Neurologic Status
5%
Standardized Mean
5%
Observational Prospective Study
5%
Clinically Important Deterioration
5%
Patient-physician
5%
Old Candidates
5%
Medicine and Dentistry
Health Care Provider
100%
Neuropathy
100%
Patient Assessment
100%
Neurotoxicity
100%
Nurse
50%
Gynecological Oncology
35%
Cancer Treatment
35%
Functional Assessment
35%
Minimal Clinically Important Difference
20%
Prospective Study
5%
Clinical Trial
5%
Deterioration
5%
Clinical Assessment
5%
Neurologic Examination
5%
Chemotherapy
5%
INIS
patients
100%
assessments
100%
chemotherapy
100%
evaluation
100%
cancer
77%
detection
22%
correlations
22%
data
11%
clinical trials
11%
usa
11%
classification
11%
european union
11%
gold
11%
australia
11%
Nursing and Health Professions
Health Care Personnel
100%
Patient Assessment
100%
Neuropathy
100%
Neurotoxicity
100%
Cancer Therapy
35%
Functional Assessment
35%
Minimal Clinically Important Difference
20%
Deterioration
5%
Gold Standard
5%
Clinical Assessment
5%
Neurologic Examination
5%
Neuroscience
Neurotoxicity
100%
Neuropathy
100%
Clinical Assessment
5%
Chemotherapy Regimens
5%